A mechanosensing mechanism controls plasma membrane shape homeostasis at the nanoscale

  1. Xarxa Quiroga
  2. Nikhil Walani
  3. Andrea Disanza
  4. Albert Chavero
  5. Alexandra Mittens
  6. Francesc Tebar
  7. Xavier Trepat
  8. Robert G Parton
  9. María Isabel Geli
  10. Giorgio Scita
  11. Marino Arroyo
  12. Anabel-Lise Le Roux  Is a corresponding author
  13. Pere Roca-Cusachs  Is a corresponding author
  1. Barcelona Institute for Science and Technology, Spain
  2. Indian Institute of Technology Delhi, India
  3. AIRC Institute of Molecular Oncology, Italy
  4. Universitat de Barcelona, Spain
  5. University of Queensland, Australia
  6. Institute for Molecular Biology of Barcelona, Spain
  7. Universitat Politècnica de Catalunya, Spain

Abstract

As cells migrate and experience forces from their surroundings, they constantly undergo mechanical deformations which reshape their plasma membrane (PM). To maintain homeostasis, cells need to detect and restore such changes, not only in terms of overall PM area and tension as previously described, but also in terms of local, nano-scale topography. Here we describe a novel phenomenon, by which cells sense and restore mechanically induced PM nano-scale deformations. We show that cell stretch and subsequent compression reshape the PM in a way that generates local membrane evaginations in the 100 nm scale. These evaginations are recognized by I-BAR proteins, which triggers a burst of actin polymerization mediated by Rac1 and Arp2/3. The actin polymerization burst subsequently re-flattens the evagination, completing the mechanochemical feedback loop. Our results demonstrate a new mechanosensing mechanism for PM shape homeostasis, with potential applicability in different physiological scenarios.

Data availability

Source data is provided for all figures in a corresponding source data file.

Article and author information

Author details

  1. Xarxa Quiroga

    Institute for Bioengineering of Catalonia, Barcelona Institute for Science and Technology, Barcelona, Spain
    Competing interests
    No competing interests declared.
  2. Nikhil Walani

    Department of Applied Mechanics, Indian Institute of Technology Delhi, Delhi, India
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5248-9181
  3. Andrea Disanza

    IFOM Foundation, AIRC Institute of Molecular Oncology, Milan, Italy
    Competing interests
    No competing interests declared.
  4. Albert Chavero

    Departament de Biomedicina, Universitat de Barcelona, Barcelona, Spain
    Competing interests
    No competing interests declared.
  5. Alexandra Mittens

    Institute for Bioengineering of Catalonia, Barcelona Institute for Science and Technology, Barcelona, Spain
    Competing interests
    No competing interests declared.
  6. Francesc Tebar

    Departament de Biomedicina, Universitat de Barcelona, Barcelona, Spain
    Competing interests
    No competing interests declared.
  7. Xavier Trepat

    Institute for Bioengineering of Catalonia, Barcelona Institute for Science and Technology, Barcelona, Spain
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7621-5214
  8. Robert G Parton

    Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7494-5248
  9. María Isabel Geli

    Institute for Molecular Biology of Barcelona, Barcelona, Spain
    Competing interests
    María Isabel Geli, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3452-6700
  10. Giorgio Scita

    IFOM Foundation, AIRC Institute of Molecular Oncology, Milan, Italy
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7984-1889
  11. Marino Arroyo

    Universitat Politècnica de Catalunya, Barcelona, Spain
    Competing interests
    No competing interests declared.
  12. Anabel-Lise Le Roux

    Institute for Bioengineering of Catalonia, Barcelona Institute for Science and Technology, Barcelona, Spain
    For correspondence
    aleroux@ibecbarcelona.eu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4152-5658
  13. Pere Roca-Cusachs

    Institute for Bioengineering of Catalonia, Barcelona Institute for Science and Technology, Barcelona, Spain
    For correspondence
    proca@ibecbarcelona.eu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6947-961X

Funding

Ministerio de Ciencia e Innovación (PID2019-110298GB-I00)

  • Pere Roca-Cusachs

Institució Catalana de Recerca i Estudis Avançats (ICREA Acadèmia Prize)

  • Marino Arroyo
  • Pere Roca-Cusachs

Ministerio de Ciencia e Innovación (PGC2018-099645-B-I00)

  • Xavier Trepat

Ministerio de Ciencia e Innovación (BFU2016-79916-P)

  • Xarxa Quiroga

European Commission (H2020-FETPROACT-01-2016-731957)

  • Xavier Trepat
  • Marino Arroyo
  • Pere Roca-Cusachs

Generalitat de Catalunya (2021 SGR 01425)

  • Xavier Trepat
  • Pere Roca-Cusachs

Fundació la Marató de TV3 (201936-30-31)

  • Pere Roca-Cusachs

'la Caixa' Foundation (LCF/PR/HR20/52400004)

  • Pere Roca-Cusachs

Ministerio de Ciencia e Innovación (BFU2015-66785-P)

  • Francesc Tebar

Associazione Italiana per la Ricerca sul Cancro (AIRC-IG 18621 and 1311 5XMille22759)

  • Giorgio Scita

italian ministry of university (PRIN 2017-Prot. 1313 2017HWTP2K)

  • Giorgio Scita

European Research Council (Adv-883739)

  • Xavier Trepat

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2023, Quiroga et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,507
    views
  • 462
    downloads
  • 13
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Xarxa Quiroga
  2. Nikhil Walani
  3. Andrea Disanza
  4. Albert Chavero
  5. Alexandra Mittens
  6. Francesc Tebar
  7. Xavier Trepat
  8. Robert G Parton
  9. María Isabel Geli
  10. Giorgio Scita
  11. Marino Arroyo
  12. Anabel-Lise Le Roux
  13. Pere Roca-Cusachs
(2023)
A mechanosensing mechanism controls plasma membrane shape homeostasis at the nanoscale
eLife 12:e72316.
https://doi.org/10.7554/eLife.72316

Share this article

https://doi.org/10.7554/eLife.72316

Further reading

    1. Cell Biology
    2. Genetics and Genomics
    Keva Li, Nicholas Tolman ... UK Biobank Eye and Vision Consortium
    Research Article

    A glaucoma polygenic risk score (PRS) can effectively identify disease risk, but some individuals with high PRS do not develop glaucoma. Factors contributing to this resilience remain unclear. Using 4,658 glaucoma cases and 113,040 controls in a cross-sectional study of the UK Biobank, we investigated whether plasma metabolites enhanced glaucoma prediction and if a metabolomic signature of resilience in high-genetic-risk individuals existed. Logistic regression models incorporating 168 NMR-based metabolites into PRS-based glaucoma assessments were developed, with multiple comparison corrections applied. While metabolites weakly predicted glaucoma (Area Under the Curve = 0.579), they offered marginal prediction improvement in PRS-only-based models (p=0.004). We identified a metabolomic signature associated with resilience in the top glaucoma PRS decile, with elevated glycolysis-related metabolites—lactate (p=8.8E-12), pyruvate (p=1.9E-10), and citrate (p=0.02)—linked to reduced glaucoma prevalence. These metabolites combined significantly modified the PRS-glaucoma relationship (Pinteraction = 0.011). Higher total resilience metabolite levels within the highest PRS quartile corresponded to lower glaucoma prevalence (Odds Ratiohighest vs. lowest total resilience metabolite quartile=0.71, 95% Confidence Interval = 0.64–0.80). As pyruvate is a foundational metabolite linking glycolysis to tricarboxylic acid cycle metabolism and ATP generation, we pursued experimental validation for this putative resilience biomarker in a human-relevant Mus musculus glaucoma model. Dietary pyruvate mitigated elevated intraocular pressure (p=0.002) and optic nerve damage (p<0.0003) in Lmx1bV265D mice. These findings highlight the protective role of pyruvate-related metabolism against glaucoma and suggest potential avenues for therapeutic intervention.

    1. Cell Biology
    Affiong Ika Oqua, Kin Chao ... Alejandra Tomas
    Research Article

    G protein-coupled receptors (GPCRs) are integral membrane proteins which closely interact with their plasma membrane lipid microenvironment. Cholesterol is a lipid enriched at the plasma membrane with pivotal roles in the control of membrane fluidity and maintenance of membrane microarchitecture, directly impacting on GPCR stability, dynamics, and function. Cholesterol extraction from pancreatic beta cells has previously been shown to disrupt the internalisation, clustering, and cAMP responses of the glucagon-like peptide-1 receptor (GLP-1R), a class B1 GPCR with key roles in the control of blood glucose levels via the potentiation of insulin secretion in beta cells and weight reduction via the modulation of brain appetite control centres. Here, we unveil the detrimental effect of a high cholesterol diet on GLP-1R-dependent glucoregulation in vivo, and the improvement in GLP-1R function that a reduction in cholesterol synthesis using simvastatin exerts in pancreatic islets. We next identify and map sites of cholesterol high occupancy and residence time on active vs inactive GLP-1Rs using coarse-grained molecular dynamics (cgMD) simulations, followed by a screen of key residues selected from these sites and detailed analyses of the effects of mutating one of these, Val229, to alanine on GLP-1R-cholesterol interactions, plasma membrane behaviours, clustering, trafficking and signalling in INS-1 832/3 rat pancreatic beta cells and primary mouse islets, unveiling an improved insulin secretion profile for the V229A mutant receptor. This study (1) highlights the role of cholesterol in regulating GLP-1R responses in vivo; (2) provides a detailed map of GLP-1R - cholesterol binding sites in model membranes; (3) validates their functional relevance in beta cells; and (4) highlights their potential as locations for the rational design of novel allosteric modulators with the capacity to fine-tune GLP-1R responses.